| P50 | author | Michael Camilleri | Q64750736 |
| P2093 | author name string | Madhusudan Grover | |
| P2860 | cites work | Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome | Q33960506 |
| | Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea | Q35350975 |
| | Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. | Q36297736 |
| | Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? | Q36715880 |
| | Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials | Q36983944 |
| | Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome | Q37057059 |
| | A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program | Q37130608 |
| | Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats | Q37434409 |
| | Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis | Q37496549 |
| | The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies | Q37887773 |
| | Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome | Q38102063 |
| | Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea | Q39215989 |
| | A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome | Q39316382 |
| | A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. | Q39371837 |
| | Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue | Q41969757 |
| | Role of the serotonin3 receptor in stress-induced defecation | Q43310501 |
| | Involvement of the 5-HT3 receptor in CRH-induce defecation in rats | Q43333274 |
| | Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome | Q43746131 |
| | Excitation of rat colonic afferent fibres by 5-HT(3) receptors. | Q44201747 |
| | Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer | Q44337621 |
| | Alosetron repeat dose pharmacokinetics, effects on enzyme activities, and influence of demographic factors | Q44963267 |
| | Sex-related differences in IBS patients: central processing of visceral stimuli | Q48281142 |
| | Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. | Q50862970 |
| | GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. | Q51616453 |
| | Dual role of 5-HT3 receptors in a rat model of delayed stress-induced visceral hyperalgesia. | Q51999561 |
| | Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome | Q72968723 |
| | Gender differences in regional brain response to visceral pressure in IBS patients | Q74220110 |
| | Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex | Q77181268 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| | irritable bowel syndrome | Q838966 |
| P304 | page(s) | 960-962 | |
| P577 | publication date | 2014-01-03 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story? | |
| P478 | volume | 12 | |